Literature DB >> 22302679

Effect of age on aldosterone/renin ratio (ARR) and comparison of screening accuracy of ARR plus elevated serum aldosterone concentration for primary aldosteronism screening in different age groups.

Guoshu Yin1, Shaoling Zhang, Li Yan, Muchao Wu, Mingtong Xu, Feng Li, Hua Cheng.   

Abstract

The serum aldosterone concentration (SAC)/plasma renin activity (PRA) ratio (ARR) is considered a useful screening test in the differential diagnosis of essential hypertension (EH) and primary aldosteronism (PA). The purpose of this study is to investigate the effect of age on ARR and compare the screening accuracy of ARR plus elevated SAC for PA screening in different age groups. Thirty-nine patients with PA, 274 patients with EH, and 153 healthy volunteers were recruited. Blood was sampled for SAC and PRA measuring under keeping upright posture for 1 h. Levels of SAC, PRA, and ARR were compared at different ages range for the respective three groups of subjects. The screening accuracy of ARR plus elevated SAC was compared in different age groups and PA patients served as the same positive subjects. In the EH group, logarithmically transformed ARR (Log-ARR) increased with advancing age and reached its peak in the ≥ 60 years group; in the normotensives group, Log-ARR reached its peak in the 40-49 years group and slightly declined with advancing age. In the PA group, Log-ARR was not age dependent. Screening accuracy increased when combined index of ARR and SAC was used in the ≥ 40 years group but not in the <40 years group. Although the number of EH patients with elevated ARR increased with advancing age, but the screening accuracy and cutoff values of ARR were not affected by age. Using the combined index of ARR and SAC increased the screening accuracy for the patients older than 40 years, but not necessary for the patients younger than 40 years.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22302679     DOI: 10.1007/s12020-012-9609-z

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  36 in total

1.  Hyperaldosteronism among black and white subjects with resistant hypertension.

Authors:  David A Calhoun; Mari K Nishizaka; Mohammad A Zaman; Roopal B Thakkar; Paula Weissmann
Journal:  Hypertension       Date:  2002-12       Impact factor: 10.190

2.  Role for adrenal venous sampling in primary aldosteronism.

Authors:  William F Young; Anthony W Stanson; Geoffrey B Thompson; Clive S Grant; David R Farley; Jon A van Heerden
Journal:  Surgery       Date:  2004-12       Impact factor: 3.982

3.  Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study.

Authors:  Gilberta Giacchetti; Vanessa Ronconi; Federica Turchi; Laura Agostinelli; Franco Mantero; Silvia Rilli; Marco Boscaro
Journal:  J Hypertens       Date:  2007-01       Impact factor: 4.844

Review 4.  Primary aldosteronism: from bench to bedside.

Authors:  Norlela Sukor
Journal:  Endocrine       Date:  2011-11-01       Impact factor: 3.633

5.  Reference intervals for aldosterone, renin, and the aldosterone-to-renin ratio in the population-based Study of Health in Pomerania (SHIP-1).

Authors:  A Hannemann; N Friedrich; J Lüdemann; H Völzke; R Rettig; J Peters; M Reincke; A Döring; M Nauck; H Wallaschofski
Journal:  Horm Metab Res       Date:  2010-02-15       Impact factor: 2.936

6.  Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan.

Authors:  Masao Omura; Jun Saito; Kunio Yamaguchi; Yukio Kakuta; Tetsuo Nishikawa
Journal:  Hypertens Res       Date:  2004-03       Impact factor: 3.872

7.  Comparison of active renin concentration and plasma renin activity for the diagnosis of primary hyperaldosteronism in patients with an adrenal mass.

Authors:  Nicole Unger; Ingo Lopez Schmidt; Christian Pitt; Martin K Walz; Thomas Philipp; Klaus Mann; Stephan Petersenn
Journal:  Eur J Endocrinol       Date:  2004-04       Impact factor: 6.664

8.  Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents.

Authors:  Paolo Mulatero; Michael Stowasser; Keh-Chuan Loh; Carlos E Fardella; Richard D Gordon; Lorena Mosso; Celso E Gomez-Sanchez; Franco Veglio; William F Young
Journal:  J Clin Endocrinol Metab       Date:  2004-03       Impact factor: 5.958

9.  Primary aldosteronism in diabetic subjects with resistant hypertension.

Authors:  Guillermo E Umpierrez; Paul Cantey; Dawn Smiley; Andres Palacio; Diana Temponi; Karen Luster; Arlene Chapman
Journal:  Diabetes Care       Date:  2007-04-11       Impact factor: 19.112

10.  A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Results in hypertensive patients.

Authors:  K Hiramatsu; T Yamada; Y Yukimura; I Komiya; K Ichikawa; M Ishihara; H Nagata; T Izumiyama
Journal:  Arch Intern Med       Date:  1981-11
View more
  7 in total

1.  Potential effects of age on screening for primary aldosteronism.

Authors:  Q Luo; N F Li; X G Yao; D L Zhang; S F Y Abulikemu; G J Chang; K M Zhou; G L Wang; M H Wang; W J Ouyang; Q Y Cheng; Y Jia
Journal:  J Hum Hypertens       Date:  2015-04-16       Impact factor: 3.012

Review 2.  Primary aldosteronism: a common cause of resistant hypertension.

Authors:  Gregory A Kline; Ally P H Prebtani; Alexander A Leung; Ernesto L Schiffrin
Journal:  CMAJ       Date:  2017-06-05       Impact factor: 8.262

3.  NT-proBNP, a useful tool in hypertensive patients undergoing a diagnostic evaluation for primary aldosteronism.

Authors:  Francesca Pizzolo; Francesco Zorzi; Laura Chiecchi; Letizia Consoli; Irene Aprili; Patrizia Guarini; Annalisa Castagna; Gian Luca Salvagno; Chiara Pavan; Oliviero Olivieri
Journal:  Endocrine       Date:  2013-08-13       Impact factor: 3.633

4.  Age-Related Cutoffs of Plasma Aldosterone/Renin Concentration for Primary Aldosteronism Screening.

Authors:  Linqiang Ma; Ying Song; Mei Mei; Wenwen He; Jinbo Hu; Qingfeng Cheng; Ziwei Tang; Ting Luo; Yue Wang; Qianna Zhen; Zhihong Wang; Hua Qing; Yihong He; Qifu Li; Shumin Yang
Journal:  Int J Endocrinol       Date:  2018-07-16       Impact factor: 3.257

5.  The Association between eGFR and the Aldosterone-to-Renin Ratio and Its Effect on Screening for Primary Aldosteronism.

Authors:  Jing Xu; Yumei Yang; Yan Ling; Zhiqiang Lu; Xin Gao; Xiaomu Li; Xiaoying Li
Journal:  Int J Endocrinol       Date:  2020-02-07       Impact factor: 3.257

Review 6.  Confounders of the aldosterone-to-renin ratio when used as a screening test in hypertensive patients: A critical analysis of the literature.

Authors:  Gregory P Veldhuizen; Rawan M Alnazer; Abraham A Kroon; Peter W de Leeuw
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-12-27       Impact factor: 3.738

7.  Survey of renin and aldosterone testing practices by Ontario laboratories - Providing insight into best practices.

Authors:  Angela C Rutledge; Anna Johnston; Dana Bailey; Ronald A Booth; Pamela Edmond; Victor Leung; Kika Veljkovic
Journal:  Pract Lab Med       Date:  2021-04-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.